Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - remifentanil hydrochloride; remifentanil [as hydrochloride] -

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 5.485 mg (equivalent: remifentanil, qty 5 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty 2 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty 1 mg) - injection, powder for - excipient ingredients: glycine - ultiva for injection is indicated- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults; as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical but not cardiac procedures in children aged 1 to 12 years; for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery-when endotracheal intubation and controlled ventillation are anticipated. for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 1 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 2 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.

Israel - English - Ministry of Health

lapidot medical import and marketing ltd - remifentanil as hydrochloride - powder for concentrate for solution for injection / infusion - remifentanil as hydrochloride 5 mg - remifentanil - remifentanil b.braun is indicated as an analgesic agent for use during induction and/or maintenance of general anaesthesia under close supervision .remifentanil b.braun is indicated for provision of analgesia and sedation in mechanically ventilated intensive care patients 18 years of age and over.